2.27
4.13%
0.09
After Hours:
2.27
Creative Medical Technology Holdings Inc stock is traded at $2.27, with a volume of 8,355.
It is up +4.13% in the last 24 hours and down -0.87% over the past month.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.
See More
Previous Close:
$2.18
Open:
$2.19
24h Volume:
8,355
Relative Volume:
0.20
Market Cap:
$3.97M
Revenue:
$102.80K
Net Income/Loss:
$-5.32M
P/E Ratio:
-0.5974
EPS:
-3.8
Net Cash Flow:
$-5.45M
1W Performance:
+4.61%
1M Performance:
-0.87%
6M Performance:
-38.06%
1Y Performance:
-48.81%
Creative Medical Technology Holdings Inc Stock (CELZ) Company Profile
Name
Creative Medical Technology Holdings Inc
Sector
Industry
Phone
480-399-2822
Address
211 E. OSBORN RD., PHOENIX
Compare CELZ with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
CELZ
Creative Medical Technology Holdings Inc
|
2.27 | 3.97M | 102.80K | -5.32M | -5.45M | -3.80 |
VRTX
Vertex Pharmaceuticals Inc
|
422.00 | 108.68B | 10.63B | -479.80M | -1.35B | -1.99 |
REGN
Regeneron Pharmaceuticals Inc
|
681.58 | 74.90B | 13.85B | 4.65B | 3.32B | 40.41 |
ARGX
Argen X Se Adr
|
640.52 | 38.30B | 1.86B | -40.29M | -1.28B | -0.85 |
ALNY
Alnylam Pharmaceuticals Inc
|
246.27 | 31.76B | 2.09B | -332.26M | 16.06M | -2.62 |
BNTX
Biontech Se Adr
|
111.93 | 26.83B | 3.30B | -501.07M | 1.03B | -2.1146 |
Creative Medical Technology Holdings Inc Stock (CELZ) Latest News
CELZ (Creative Medical Technology Holdings) 3-Year Revenue Growth Rate : -87.20% (As of Sep. 2024) - GuruFocus.com
Bunion correction systems Market Key Players AnalysisStryker - openPR
Creative Global Technology Holdings Ltd's Quiet Period Set To End on January 6th (NASDAQ:CGTL) - MarketBeat
Orange County Bancorp Announces Two-for-One Stock Split - Defense World
Optical Cable Corporation Releases Fourth Quarter and Fiscal Year 2024 Financial Results - Defense World
TechPrecision Corporation Announces Corporate Changes Following Annual Meeting - Defense World
Versus Systems Completes Corporate Continuance and Securities Issuance - Defense World
Creative Medical Technology Holdings, Inc. Reports Amendment to Articles of Incorporation and Voting Results Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) filed a Form 8-K with the Securities and Exchange Commission on December 19, 20 - Defense World
Mergers & Acquisitions Tracker - Plastics News
CELZ stock touches 52-week low at $2.11 amid market challenges - Investing.com India
Creative Global Technology Holdings Ltd trading resumes - Nasdaq
CELZ stock touches 52-week low at $2.21 amid market challenges - Investing.com Australia
CELZ stock touches 52-week low at $2.36 amid market challenges By Investing.com - Investing.com South Africa
CELZ stock touches 52-week low at $2.36 amid market challenges - Investing.com Canada
CELZ (Creative Medical Technology Holdings) 9-Day RSI : 39.05 (As of Nov. 28, 2024) - GuruFocus.com
Creative Global Tech opens at $4.29, IPO priced at $4 per share - Yahoo Finance
Creative Global Technology Holdings Limited Announces Closings of Its Initial Public Offering and the Underwriter’s Over-Allotment Option - Yahoo Finance
Degenerative Disc Disease Market Size in the 7MM was ~USD 3,600 Million in 2023, estimated DelveInsight - openPR
Creative Global Technology Holdings Limited Announces Pricing of Its Initial Public Offering - Yahoo Finance
CELZ (Creative Medical Technology Holdings) 3-Year FCF Grow - GuruFocus.com
CELZ (Creative Medical Technology Holdings) Cash, Cash Equi - GuruFocus.com
CELZ (Creative Medical Technology Holdings) Total Inventories : $0.00 Mil (As of Sep. 2024) - GuruFocus.com
CELZ stock touches 52-week low at $2.49 amid market challenges - Investing.com Australia
CELZ stock touches 52-week low at $2.49 amid market challenges By Investing.com - Investing.com South Africa
Can Creative Global Technology Holdings Limited's (NASDAQ:CGTL) ROE Continue To Surpass The Industry Average? - Yahoo Finance
Equities Analysts Issue Forecasts for CELZ FY2024 Earnings - Defense World
Novozymes A/S (OTCMKTS:NVZMY) & Creative Medical Technology (NASDAQ:CELZ) Head-To-Head Comparison - Defense World
Q1 Earnings Estimate for CELZ Issued By Roth Capital - Defense World
Creative Medical Technology files to sell 0.83M shares of common stocks by selling shareholders - MSN
Creative Technology (SGX:C76) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance
Mesa medical manufacturer BioLab Holdings Inc. hires new COO - Daily Independent
Creative Medical Technology Holdings, Inc. Advances FDA Cleared ADAPT Clinical Trial with Positive Independent - EIN News
Creative Medical Technology Holdings, Inc. Advances FDA Cleared ADAPT Clinical Trial with Positive Independent Review, Validating the Safety and Potential of CELZ-201 for Chronic Lower Back Pain Treatment - The Manila Times
Electrify Expo Expands to New Markets in 2025 as Dallas and Chicago Join the Nation's Largest EV Festival - The Manila Times
Creative Medical passes safety review for back pain trial By Investing.com - Investing.com UK
Creative Medical Tech's CELZ-201 Back Pain Trial Advances After Positive Safety Review | CELZ Stock News - StockTitan
Creative Planning Lowers Holdings in Mirion Technologies, Inc. (NYSE:MIR) - Defense World
Weekly TechBio News: ADMET Prediction - substack.com
Creative Planning Buys New Stake in GigaCloud Technology Inc. (NASDAQ:GCT) - Defense World
Creative Medical Technology Holdings Third Quarter 2024 Earnings: US$0.75 loss per share (vs US$1.02 loss in 3Q 2023) - Yahoo Finance UK
Creative Planning Purchases 22,171 Shares of Alphatec Holdings, Inc. (NASDAQ:ATEC) - Defense World
Creative Planning Has $334,000 Stock Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Defense World
Creative Medical Technology Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Creative Medical Technology Holdings Inc. (CELZ) Quarterly 10-Q Report - Quartzy
CELZ stock touches 52-week low at $2.65 amid market challenges - Investing.com Australia
Creative Planning Takes Position in Credo Technology Group Holding Ltd (NASDAQ:CRDO) - MarketBeat
Creative Medical Technology Holdings Inc (CELZ) Quarterly 10-Q Report - Quartz
Creative Planning Raises Holdings in Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
Creative Planning Increases Holdings in Universal Health Realty Income Trust (NYSE:UHT) - Defense World
Creative Planning Has $485,000 Stock Position in SS&C Technologies Holdings, Inc. (NASDAQ:SSNC) - Defense World
Creative Planning Reduces Stock Holdings in ProShares Ultra Technology (NYSEARCA:ROM) - Defense World
Creative Medical Technology Holdings Inc Stock (CELZ) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):